13F HOLDINGS REPORT
Lion Point Capital, LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001013594-25-001425
Total Value
$17.6M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MINERALYS THERAPEUTICS INC | MLYS | 39,000 | $1.5M | 8.40% |
| 2 | MILESTONE PHARMACEUTICALS IN | MIST | 658,553 | $1.3M | 7.48% |
| 3 | FENNEC PHARMACEUTICALS INC | FENC | 123,000 | $1.2M | 6.54% |
| 4 | JASPER THERAPEUTICS INC | JSPRW | 398,558 | $948,568 | 5.39% |
| 5 | AVADEL PHARMACEUTICALS PLC | G29687103 | 59,700 | $911,619 | 5.18% |
| 6 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 23,400 | $908,622 | 5.16% |
| 7 | INSMED INC | INSM | 6,250 | $900,063 | 5.11% |
| 8 | ARDELYX INC | ARDX | 162,750 | $896,753 | 5.09% |
| 9 | BENITEC BIOPHARMA INC | BNTC | 62,000 | $869,860 | 4.94% |
| 10 | SYNDAX PHARMACEUTICALS INC | SNDX | 55,000 | $846,175 | 4.81% |
| 11 | ROYALTY PHARMA PLC | RPRX | 21,400 | $754,992 | 4.29% |
| 12 | DISC MEDICINE INC | IRON | 10,600 | $700,448 | 3.98% |
| 13 | BRIDGEBIO PHARMA INC | BBIO | 13,300 | $690,802 | 3.92% |
| 14 | GERON CORP | GERN | 500,000 | $685,000 | 3.89% |
| 15 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 35,300 | $665,405 | 3.78% |
| 16 | REGENXBIO INC | RGNX | 57,750 | $557,288 | 3.17% |
| 17 | SERES THERAPEUTICS INC | MCRB | 27,138 | $522,135 | 2.97% |
| 18 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 67,500 | $483,975 | 2.75% |
| 19 | KURA ONCOLOGY INC | KURA | 46,000 | $407,100 | 2.31% |
| 20 | BIOHAVEN LTD | BHVN | 22,700 | $340,727 | 1.94% |
| 21 | COMPASS PATHWAYS PLC | CMPS | 58,000 | $332,340 | 1.89% |
| 22 | PRAXIS PRECISION MEDICINES I | PRAX | 5,700 | $302,100 | 1.72% |
| 23 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 42,000 | $296,100 | 1.68% |
| 24 | ROCKET PHARMACEUTICALS INC | RCKTW | 86,000 | $280,360 | 1.59% |
| 25 | MERSANA THERAPEUTICS INC | 59045L205 | 25,760 | $199,898 | 1.14% |
| 26 | HUMACYTE INC | HUMAW | 83,500 | $145,290 | 0.83% |
| 27 | SPRUCE BIOSCIENCES INC | SPRB | 1,000 | $8,950 | 0.05% |